This edition of Orrick’s series of life sciences publications breaks down the record venture investment into US-based life sciences companies in 2020 and strong showing in Q1 2021. Key findings include: • US-based life sciences companies closed 465 venture deals in Q1 2021 for a quarterly record value of $12.2 billion.
Please see full publication below for more information.
LOADING PDF: If there are any problems, click here to download the file.